Immunostimulatory compositions
US10857227B2 · kind B2 · utility
1Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 25, 2016 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | Mar 19, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6093
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of melanin, complexed with an antigen, as a immunostimulatory composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.